Back to EPRX

Aisling Capital Management LP → EPRX

Aisling Capital Management LP EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
3
Latest value
$3M
Q3 2026
Peak value
$3M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$2.4M
Q2 2026$2.1M
Q3 2026$3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3M325.0K——
Q2 2026$2.1M325.0K——
Q1 2026$2.4M325.0K——

Other funds holding EPRX

Other Aisling Capital Management LP positions

BBIO

BridgeBio Pharma Inc. (BBIO)

$389.3M
BBIO

BridgeBio Pharma Inc. (BBIO)

$378M
BBIO

BRIDGEBIO PHARMA INC

$341.8M
BBIO

BRIDGEBIO PHARMA INC

$203.3M
MNST

MONTE ROSA THERAPEUTICS INC

$37.6M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$30.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$28.8M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$27.7M